Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$317K Sell
4,698
-100
-2% -$6.64K 0.02% 238
2025
Q2
$313K Buy
4,798
+75
+2% +$4.5K 0.02% 230
2025
Q1
$292K Sell
4,723
-25
-0.5% -$1.66K 0.02% 224
2024
Q4
$342K Sell
4,748
-100
-2% -$7.81K 0.02% 197
2024
Q3
$395K Sell
4,848
-89
-2% -$7.12K 0.03% 162
2024
Q2
$367K Buy
4,937
+1,675
+51% +$126K 0.03% 160
2024
Q1
$254K Hold
3,262
0.02% 193
2023
Q4
$233K Hold
3,262
0.02% 240
2023
Q3
$226K Hold
3,262
0.02% 193
2023
Q2
$264K Buy
3,262
+14
+0.4% +$1.14K 0.02% 189
2023
Q1
$262K Hold
3,248
0.03% 184
2022
Q4
$243K Hold
3,248
0.03% 182
2022
Q3
$210K Buy
+3,248
New +$225K 0.03% 184

Other funds holding HOLX

Apexium Financial's HOLX Position: Q3 2025 in Review

Apexium Financial reduced its Hologic (HOLX) stake by 2.1% in Q3 2025, selling an estimated $6.64K and leaving 4,698 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #238.

Apexium Financial first reported a position in HOLX in Q3 2022 and has held it in 13 quarters since. The position peaked at $395K in Q3 2024. 738 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • Apexium Financial held 4,698 shares of Hologic worth $317K as of Q3 2025.
  • Apexium Financial sold 100 Hologic shares in Q3 2025, an estimated $6.64K.
  • Hologic made up 0.02% of Apexium Financial's portfolio in Q3 2025, its #238 holding.
  • Apexium Financial first reported a position in Hologic in Q3 2022 and has held it in 13 quarters since.
  • Apexium Financial's Hologic position peaked at $395K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.